Clinics in Arkansas

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What Arkansas law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Arkansas at a glance

Pharmacy regulator: Arkansas State Board of Pharmacy
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async not allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving Arkansas

No verified clinics serving Arkansas are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Arkansas

Yes, with a stricter first-visit rule than most states. An Arkansas resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Arkansas-licensed provider, including by telemedicine under the Arkansas Telemedicine Act (Ark. Code 17-80-401 through 17-80-407), but a new telemedicine patient relationship cannot rest on an internet questionnaire, email, text message, or patient-generated history alone; it needs an in-person exam, an existing relationship, referral, or coverage arrangement, or an evaluation by an Arkansas-licensed provider who has the patient's health record and uses appropriate technology, which for non-controlled drugs can include the telephone. Compounded peptides are available only when eligible under federal 503A rules and dispensed by an Arkansas-licensed pharmacy; an out-of-state pharmacy shipping into Arkansas must hold an Arkansas pharmacy license and keep an Arkansas-licensed pharmacist on staff as pharmacist in charge. [1] [2] [3] [4] [5] [6] [7] [8] [9] [12]

Compounded GLP-1 access in Arkansas

Compounded semaglutide and tirzepatide are limited to documented patient-specific needs after the FDA shortage allowances ended in 2025, and Arkansas's own compounding regulation separately bars routine copies of commercially available drugs. Because Arkansas law does not let an online questionnaire alone establish the patient relationship, Arkansas patients should expect a live evaluation (in person, by video, or by telephone backed by a health record) before a first GLP-1 prescription, and should confirm the dispensing pharmacy holds an Arkansas license with an Arkansas-licensed pharmacist in charge. [3] [5] [7] [13]

Research use only sellers in Arkansas

Only Arkansas-licensed pharmacies may dispense prescription drugs to Arkansas patients, including out-of-state pharmacies licensed under Ark. Code 17-92-401. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and carry no Arkansas licensing protections. The Arkansas Food, Drug, and Cosmetic Act (Ark. Code 20-56-201 and following) has no separate new-drug approval section, so the unapproved-drug prohibition comes from federal law; the state act does prohibit selling a misbranded drug (Ark. Code 20-56-215) and treats a drug as misbranded unless its labeling bears adequate directions for use and adequate warnings (Ark. Code 20-56-211). [5] [10] [11] [14]

Arkansas notes on specific peptides

Semaglutide: Available branded by prescription. A first prescription by telemedicine requires a professional relationship under Ark. Code 17-80-402 and 17-80-403, such as an in-person exam, an existing relationship or referral, or an evaluation by an Arkansas-licensed provider with access to the patient's health record (telephone allowed for non-controlled drugs); a questionnaire alone does not qualify. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [3] [13]
Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to documented patient-specific needs since the 503A grace period ended February 18, 2025, and an out-of-state pharmacy shipping it to Arkansas must hold an Arkansas license with an Arkansas-licensed pharmacist in charge. [5] [13]

How to check a clinic in Arkansas

Confirm the prescribing clinician's license with the Arkansas medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the Arkansas State Board of Pharmacy license lookup. [1] [5] [6] [7] [12]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Arkansas. [5] [10] [11] [14]

Common questions in Arkansas

Can I get a GLP-1 prescription in Arkansas from an online questionnaire alone?

No. The Arkansas Telemedicine Act requires a professional relationship before telemedicine care and says an internet questionnaire, email, text message, or patient-generated medical history alone does not create one. For a new patient the relationship can come from an in-person exam, a referral from a professional who knows you, or an evaluation by an Arkansas-licensed provider who has your health record and uses appropriate technology, which for non-controlled drugs such as GLP-1s can include a telephone call. After the relationship exists, follow-up can be asynchronous. [2] [3] [8]

Does a telehealth prescriber need an Arkansas license?

Yes. Ark. Code 17-80-404 requires a professional treating a patient located in Arkansas through telemedicine to be fully licensed in Arkansas. Check the prescriber on the Arkansas State Medical Board license lookup before paying. [4]

All peptide legal questions for Arkansas